| Recruiting | 1/2 | 29 | US | Atezolizumab, Tecentriq, Tivozanib, Fotivda | University of Florida, Genentech, Inc., Aveo Oncology Pharmaceuticals | Bile Duct Cancer, Gall Bladder Cancer, Breast Cancer, Neuroendocrine Tumors, Ovarian Cancer, Pancreatic Adenocarcinoma, Soft Tissue Sarcoma, Vulvar Cancer, Prostate Cancer | 12/24 | 12/25 | | |